HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Metastatic Squamous Neck Cancer with Occult Primary Treatment (Adult) (PDQ®)–Patient Version

cancer  treatment  patient  version  metastatic  squamous  neck  occult  metastatic squamous neck cancer with occult primary  adult metastatic squamous neck cancer with occult primary 

Metastatic squamous neck cancer with occult primary (unknown primary) treatment options include surgery, radiation therapy, or a combination of both. Learn more about the diagnosis and treatment of these tumors in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

Metastatic Squamous Neck Cancer With Occult Primary Treatment (Adult) (PDQ®)–Health Professional Version

cancer  health  treatment  version  professional  metastatic  squamous  neck  occult  metastatic squamous neck cancer with occult primary  adult metastatic squamous neck cancer with occult primary 

Metastatic squamous neck cancer with occult primary treatment options include surgery, radiation therapy or a combination of both. Get detailed information about newly diagnosed or recurrent metastatic squamous neck cancer in this summary for clinicians.

Preview   0 Users liked this content.
CDC

Indoor Tanning Is Not Safe | Skin Cancer

facts  cancer  statistics  CDC  dangers  skin  melanoma  carcinoma  squamous  indoor tanning  ocular 

Indoor tanning can cause skin cancers including melanoma (the deadliest type of skin cancer), basal cell carcinoma, and squamous cell carcinoma.

Preview   0 Users liked this content.
NCI

Lung-MAP: Master Protocol for Lung Cancer

lung  squamous  protocol  nctn  lung-map  non-small cell 

The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.

Preview   0 Users liked this content.